Genvor Inc
corporate_fare Company Profile
Genvor Inc (OTC:GNVR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for GNVR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-26, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for GNVR spans 8-K, 10-Q, DEF 14C, PRE 14C.
Recent high-impact activity:
- Genvor Secures Full Ownership of ~9,000-Peptide Library From Founder/CSO Ahead of Nasdaq Push
- Genvor 10-Q Reveals $1.6M Tax Reimbursement Liability and New Material Weaknesses
- Genvor Finalizes Sweeping Governance Overhaul and Equity Plan, Paving Way for Reverse Split
- Genvor Inc. Majority Stockholders Greenlight Reverse Split, Equity Plan, and Sweeping Governance Overhaul
- Genvor Secures $333K in Accelerated Funding, Issues Warrants at Double Current Price
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 1,725 shares in GNVR as of the October 15, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for GNVR, detected from its recent SEC filings · based on capital-structure filings through 2026-05-13.
Substantial Doubt About Going Concern · Material Weaknesses in Internal Controls
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →